QBR-B.TO vs. JNJ
QBR-B.TO (Quebecor Inc) and JNJ (Johnson & Johnson) are both stocks. QBR-B.TO operates in Telecom Services (Communication Services), while JNJ operates in Drug Manufacturers - General (Healthcare). Over the past 10 years, QBR-B.TO returned 16.78%/yr vs 11.07%/yr for JNJ. At a 0.09 correlation, their price movements are largely independent.
Performance
QBR-B.TO vs. JNJ - Performance Comparison
Loading charts...
Different Trading Currencies
QBR-B.TO is traded in CAD, while JNJ is traded in USD. To make them comparable, the JNJ values have been converted to CAD using the latest available exchange rates.
Returns By Period
In the year-to-date period, QBR-B.TO achieves a 32.54% return, which is significantly higher than JNJ's 15.49% return. Over the past 10 years, QBR-B.TO has outperformed JNJ with an annualized return of 16.78%, while JNJ has yielded a comparatively lower 11.07% annualized return.
QBR-B.TO
- 1D
- -0.51%
- 1M
- 19.79%
- YTD
- 32.54%
- 6M
- 34.22%
- 1Y
- 77.74%
- 3Y*
- 32.13%
- 5Y*
- 20.31%
- 10Y*
- 16.78%
JNJ
- 1D
- 0.01%
- 1M
- 7.69%
- YTD
- 15.49%
- 6M
- 17.35%
- 1Y
- 56.61%
- 3Y*
- 18.23%
- 5Y*
- 13.19%
- 10Y*
- 11.07%
QBR-B.TO vs. JNJ - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
QBR-B.TO Quebecor Inc | 32.54% | 69.85% | 4.16% | 8.44% | 10.30% | -9.74% | 1.42% | 16.74% | 22.16% | 28.07% |
JNJ Johnson & Johnson | 15.49% | 40.75% | 3.25% | -10.75% | 12.69% | 11.38% | 8.19% | 11.43% | 2.85% | 16.00% |
Correlation
The correlation between QBR-B.TO and JNJ is 0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.07 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.08 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.08 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.13 |
Correlation (All Time) Calculated using the full available price history since Jul 6, 2006 | 0.09 |
Fundamentals
QBR-B.TO:
CA$15.65B
JNJ:
$567.68B
QBR-B.TO:
CA$3.85
JNJ:
$8.65
QBR-B.TO:
17.58
JNJ:
26.85
QBR-B.TO:
1.47
JNJ:
0.89
QBR-B.TO:
2.73
JNJ:
5.86
QBR-B.TO:
5.84
JNJ:
6.99
QBR-B.TO:
CA$5.73B
JNJ:
$96.36B
QBR-B.TO:
CA$2.22B
JNJ:
$66.60B
QBR-B.TO:
CA$2.40B
JNJ:
$31.62B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
QBR-B.TO vs. JNJ — Risk / Return Rank
QBR-B.TO
JNJ
QBR-B.TO vs. JNJ - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Quebecor Inc (QBR-B.TO) and Johnson & Johnson (JNJ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| QBR-B.TO | JNJ | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | 0.00 | ||
| Sortino ratioReturn per unit of downside risk | -0.38 | ||
| Omega ratioGain probability vs. loss probability | 1.56 | 1.58 | -0.02 |
| Calmar ratioReturn relative to maximum drawdown | 6.69 | 5.08 | +1.61 |
| Martin ratioReturn relative to average drawdown | 21.92 | 15.60 | +6.32 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| QBR-B.TO | JNJ | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 3.26 | 3.26 | 0.00 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.96 | 0.74 | +0.22 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.81 | 0.57 | +0.24 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.59 | 0.55 | +0.04 |
Drawdowns
QBR-B.TO vs. JNJ - Drawdown Comparison
The maximum QBR-B.TO drawdown since its inception was -65.30%, which is greater than JNJ's maximum drawdown of -27.32%. Use the drawdown chart below to compare losses from any high point for QBR-B.TO and JNJ.
Loading charts...
Drawdown Indicators
| QBR-B.TO | JNJ | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -65.30% | -27.32% | -37.98% |
Max Drawdown (1Y)Largest decline over 1 year | -11.67% | -11.20% | -0.47% |
Max Drawdown (3Y)Largest decline over 3 years | -18.43% | -15.59% | -2.84% |
Max Drawdown (5Y)Largest decline over 5 years | -25.07% | -16.71% | -8.36% |
Max Drawdown (10Y)Largest decline over 10 years | -30.06% | -20.93% | -9.13% |
Current DrawdownCurrent decline from peak | -3.56% | -4.37% | +0.81% |
Average DrawdownAverage peak-to-trough decline | -10.38% | -8.42% | -1.96% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.56% | 3.64% | -0.08% |
Volatility
QBR-B.TO vs. JNJ - Volatility Comparison
Quebecor Inc (QBR-B.TO) has a higher volatility of 10.39% compared to Johnson & Johnson (JNJ) at 6.10%. This indicates that QBR-B.TO's price experiences larger fluctuations and is considered to be riskier than JNJ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| QBR-B.TO | JNJ | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.39% | 6.10% | +4.29% |
Volatility (6M)Calculated over the trailing 6-month period | 17.95% | 13.19% | +4.76% |
Volatility (1Y)Calculated over the trailing 1-year period | 24.02% | 17.49% | +6.53% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 21.35% | 18.00% | +3.35% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 20.91% | 19.57% | +1.34% |
Dividends
QBR-B.TO vs. JNJ - Dividend Comparison
QBR-B.TO's dividend yield for the trailing twelve months is around 2.22%, less than JNJ's 2.26% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
JNJ Johnson & Johnson | 2.26% | 2.48% | 3.40% | 3.00% | 2.52% | 2.45% | 2.53% | 2.57% | 2.74% | 2.38% | 2.73% | 2.87% |
QBR-B.TO Quebecor Inc | 2.22% | 2.71% | 4.13% | 3.81% | 3.97% | 3.85% | 2.44% | 1.18% | 0.67% | 0.77% | 0.91% | 0.77% |
Financials
QBR-B.TO vs. JNJ - Financials Comparison
This section allows you to compare key financial metrics between Quebecor Inc and Johnson & Johnson. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
QBR-B.TO vs. JNJ - Profitability Comparison
QBR-B.TO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Quebecor Inc reported a gross profit of 608.10M and revenue of 1.40B. Therefore, the gross margin over that period was 43.6%.
JNJ - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Johnson & Johnson reported a gross profit of 17.20B and revenue of 24.06B. Therefore, the gross margin over that period was 71.5%.
QBR-B.TO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Quebecor Inc reported an operating income of 367.20M and revenue of 1.40B, resulting in an operating margin of 26.3%.
JNJ - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Johnson & Johnson reported an operating income of 6.40B and revenue of 24.06B, resulting in an operating margin of 26.6%.
QBR-B.TO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Quebecor Inc reported a net income of 225.40M and revenue of 1.40B, resulting in a net margin of 16.2%.
JNJ - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Johnson & Johnson reported a net income of 5.24B and revenue of 24.06B, resulting in a net margin of 21.8%.
Frequently Asked Questions
QBR-B.TO and JNJ have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for QBR-B.TO and JNJ
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer